Monitoring the Effect of a Vascular Targeting Agent on Rhabdomyosarcomas in Rats by Diffusion-Weighted MRI.

Preclinical Evaluation of Anti-angiogenic agent Roche1 by Dynamic Contrast Enhanced MRI at 1.5T

Radiographic considerations of a multi-parameter MR research protocol for evaluating human tumour microvasculature.

Serial measurements of vascular permeability using bolus-tracking perfusion MR imaging in normal-appearing brain tissue following fractionated radiotherapy for glioma

T1 and T2* weighted dynamic contrast-enhanced MRI predicts clinico-pathological response to neoadjuvant chemotherapy in primary breast cancer